Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 33

Trial Status

Completed2
Terminated1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT00991341Phase 3Completed
Red Cell Storage Duration Study
Cardiac SurgeryErythrocyte Transfusion
Principalinvestigator

Research Network

Collaboration Network

62 collaborators·100 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Paul Ness, MD

Johns Hopkins University

Similar
4 trials

Shared therapeutic areas:

Surgery, CardiacErythrocyte TransfusionInfections+2 more

Worked with same sponsors:

Carelon ResearchGenentech, Inc.+1 more
Collaborated on 3 trials
Similarity Score62%

Cassandra Josephson, MD

Emory University

Moderately Similar
4 trials

Shared therapeutic areas:

Surgery, CardiacErythrocyte TransfusionInfections+1 more

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 2 trials
Similarity Score48%

Thomas Ortel, MD

Duke University

Moderately Similar
4 trials

Shared therapeutic areas:

Surgery, CardiacErythrocyte TransfusionPurpura, Thrombotic Thrombocytopenic

Worked with same sponsors:

Carelon ResearchGenentech, Inc.+1 more
Collaborated on 2 trials
Similarity Score38%

Ronald Strauss, MD

University of Iowa

Moderately Similar
3 trials

Shared therapeutic areas:

InfectionsNeutropeniaPurpura, Thrombotic Thrombocytopenic

Worked with same sponsors:

Carelon ResearchGenentech, Inc.+1 more
Collaborated on 2 trials
Similarity Score38%

Jan McFarland, MD

Froedtert Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

InfectionsNeutropeniaPurpura, Thrombotic Thrombocytopenic

Worked with same sponsors:

Carelon ResearchGenentech, Inc.+1 more
Collaborated on 2 trials
Similarity Score38%

Darrell Triulzi, MD

University of Pittsburgh Presbyterian and Shadyside/Children's Hospital Pittsburgh

Moderately Similar
2 trials

Shared therapeutic areas:

InfectionsNeutropeniaPurpura, Thrombotic Thrombocytopenic

Worked with same sponsors:

Carelon ResearchGenentech, Inc.+1 more
Collaborated on 2 trials
Similarity Score38%

James Bussel, MD

Weill Medical College, Cornell University

Related
2 trials

Shared therapeutic areas:

InfectionsNeutropenia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score24%

Kent Berg, MD

University of Florida

Related
1 trials

Shared therapeutic areas:

Surgery, CardiacErythrocyte Transfusion

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score24%

Meghan Delaney, DO

University of Washington/Fred Hutchinson Cancer Research Center

Related
1 trials

Shared therapeutic areas:

Surgery, CardiacErythrocyte Transfusion

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score24%

Nigel Key, MD

University of North Carolina, Chapel Hill

Related
4 trials

Shared therapeutic areas:

Surgery, CardiacErythrocyte Transfusion

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00627393Phase 3PrincipalInvestigator

Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study)

InfectionNeutropenia
Completed
NCT00799773Phase 3PrincipalInvestigator

Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP)

Thrombotic Thrombocytopenic Purpura
Terminated
NCT00991341Phase 3PrincipalInvestigator

Red Cell Storage Duration Study

Cardiac SurgeryErythrocyte Transfusion
Completed

All 3 trials loaded